Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 6/10/2025Gavi Launches $224M Arbitration Claim Against Clover Biopharma Over CO...
  • 6/10/2025Merck KGaA's Pimicotinib NDA Accepted by CDE in China, Setting Course ...
  • 6/10/2025NH's DB6: China's Consumer Healthcare Market Underperformed Again in 2...
  • 6/10/2025CDE Seeks Comments on Draft Guidelines for Defining and Classifying Ad...
  • 6/10/2025CDE Seeks Public Feedback on Second Batch of 2025 External Expert Addi...
  • 6/10/2025Transpire Enters License Deal with Intragrand Pharma for Investigation...
  • 6/10/2025Green Valley Halts Sales of Alzheimer's Drug GV-971 Amid Regulatory Un...
  • 6/10/2025Innogen Pharma Files for Hong Kong Listing, Accelerates Pipeline Devel...
  • 6/10/2025GenEditBio Doses First Patient in World’s First In Vivo CRISPR Trial ...
  • 6/9/2025Kelun-Biotech Secures US$250M in Upsized HK Share Placement
  • 6/9/2025Everest Presents Positive Results from Phase 1b/2a Trial of EVER001 fo...
  • 6/9/2025Sihuan's Chinese NDA for Breast Cancer Drug Bireociclib Accepted
  • 6/9/2025China Exempts U.S. Drugs & Medical Supplies from Retaliatory Tariffs
  • 6/9/2025CDE Solicits Comments on Draft Guidance on Post-Approval Change Manage...
  • 6/9/2025YolTech's YOLT‑101 Wins FDA IND Clearance as China Licensee Salubris ...
  • 6/9/2025Livzon's siRNA Candidate YJH‑012 Approved for Clinical Entry in China
  • 6/9/2025Argo's siRNA Candidate BW‑00163 Enters Phase 2 for Hypertension
  • 6/7/2025Recent Executive Moves
  • 6/7/2025QureBio Secures ~CNY 100M in Series C1 Financing to Advance BsAb Thera...
  • 6/6/2025Zelgen and Merck Partner to Launch China's First rhTSH Therapy for Pos...
  • 6/6/2025Beigene's BGB‑16673 Enters Phase 1b Trial for Chronic Urticaria in Ch...
  • 6/6/2025Qilu Launches Phase III Trial of QL1706 + Bevacizumab
  • 6/6/2025BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia
  • 6/6/2025AstraZeneca's Imfinzi Approved in China for LS‑SCLC
  • 6/6/2025Keymed Launches First-in-Human Trial of CM518D1
  • 6/6/2025AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...
  • 6/6/2025Kelun‑Biotech Initiates Phase II Trial of PTK7‑Targeted ADC SKB518 i...
  • 6/6/2025Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...
  • 6/5/2025CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia
  • 6/5/2025Cullinan Secures Global Rights to Genrix's Velinotamig
  • Page:32/58 Total number of articles:1720: [First][<<] [30] [31] [32] [33] [34] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group